117095-83-7Relevant articles and documents
Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds
Lumangtad, Liezel A.,Claeys, Elisa,Hamal, Sunil,Intasiri, Amarawan,Basrai, Courtney,Yen-Pon, Expedite,Beenfeldt, Davison,Vermeire, Kurt,Bell, Thomas W.
, (2020/11/20)
CADA compounds selectively down-modulate human cell-surface CD4 protein and are of interest as HIV entry inhibitors and as drugs for asthma, rheumatoid arthritis, diabetes and some cancers. Postulating that fusing a pyridine ring bearing hydrophobic subst
Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV- 2 replication by antagonism of the chemokine receptor CXCR4
Bridger, Gary J.,Skerlj, Renato T.,Padmanabhan, Sreenivasan,Martellucci, Stephen A.,Henson, Geoffrey W.,Struyf, Sofie,Witvrouw, Myriam,Schols, Dominique,De Clercq, Erik
, p. 3971 - 3981 (2007/10/03)
Bis-tetraazamacrocycles such as the bicyclam AMD3100 are a class of potent and selective anti-HIV-1 and HIV-2 agents that inhibit virus replication by binding to the chemokine receptor CXCR4, the co-receptor for entry of X4 viruses. With the aim of optimi